Investigations at follow-up clinic appointments
| Coeliac | IBD | P value | Adjusted P value | General | P value | Adjusted P value | |
| Bloods | 83 (81.4%) | 43 (43.4%) | <0.001 | <0.001 | 26 (72.2%) | 0.247 | – |
| Genetic testing | 13 (12.7%) | 0 (0%) | <0.001* | 0.002 | 3 (8.3%) | 0.562* | – |
| Gastroscopy | 21 (20.6%) | 1 (1.0%) | <0.001 | <0.001 | 6 (16.7%) | 0.610 | – |
| Colonoscopy | 7 (6.9%) | 16 (16.2%) | 0.038 | 0.38 | 1 (2.8%) | 0.680* | – |
| Flexible sigmoidoscopy | 1 (1.0%) | 3 (3.0%) | 0.364* | – | 0 (0%) | 1.000* | – |
| Capsule endoscopy | 2 (2.0%) | 5 (5.1%) | 0.274* | – | 0 (0%) | 1.000* | – |
| Imaging | 4 (4.0%) | 10 (10.1%) | 0.085 | – | 1 (2.8%) | 1.000* | – |
| SeHCAT test | 2 (2.0%) | 2 (2.0%) | 1.000* | – | 0 (0%) | 1.000* | – |
| DXA scan | 15 (14.7%) | 0 (0%) | <0.001 | <0.001 | 5 (13.9%) | 0.905 | – |
| Breath tests | 2 (2.0%) | 3 (3.0%) | 0.678* | – | 0 (0%) | 1.000* | – |
| Mean number of investigations (±SD) | 2.19 (±1.41) | 1.93 (±1.35) | <0.001 | – | 1.44 (±1.23) | 0.054 | – |
Bold denotes a significant value with p<0.05.
*One or more of the cells in 2×2 table have an expected count <5, Fisher’s exact test is used to calculate p values.
DXA, dual energy x-ray absorptiometry; IBD, inflammatory bowel disease; SeHCAT, selenium homocholic acid taurine.